DOW JONES22,103.83+467.05 2.16%
S&P 5002,606.54+65.07 2.56%
NASDAQ7,726.11+223.73 2.98%

NGM Biopharmaceuticals Q4 EPS $(0.24), Sales $31.08M

NGM Biopharmaceuticals (NASDAQ:NGM) reported quarterly losses of $(0.24) per share. The company reported $31.08 million in sales this quarter.

Benzinga · 03/17/2020 20:09

NGM Biopharmaceuticals (NASDAQ:NGM) reported quarterly losses of $(0.24) per share. The company reported $31.08 million in sales this quarter.